Taoyuan County, Taiwan

Shui-Cheng Lee

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Detection by Shui-Cheng Lee

Introduction

Shui-Cheng Lee is a notable inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of cancer detection, holding a total of 3 patents. His work focuses on developing noninvasive methods for diagnosing colorectal and gastric cancers, which are crucial for improving patient outcomes.

Latest Patents

One of his latest patents is a method for colorectal cancer detection using radiolabeled anti-GRP78 peptide. This innovative technique employs nuclear imaging to detect the position and distribution of colorectal cancer tumors. It also identifies the stage of colorectal cancer by analyzing the shading value in the tumor. This method provides a safe and noninvasive clinical approach for diagnosing and tracing the level and distribution of colorectal cancer before and after treatment.

Another significant patent is a method for diagnosing gastric cancer using human neutrophil peptide 1-3. In this process, human neutrophil peptide (HNP) 1-3 serves as diagnostic and therapeutic molecular probes found in clinical tissues of gastric cancer patients. The analytical process utilizes pairs of gastric cancer tissues to identify potential biomarkers through a proteomic strategy based on matrix-assisted laser desorption ionization-imaging mass spectrometry (MALDI-IMS). Three differential biomarkers, including HNP-1, -2, and -3, have been identified and overexpressed in gastric cancer. The validation of these proteins through western blotting and immunohistochemistry enhances their utility in clinical diagnosis and therapy for gastric cancer.

Career Highlights

Shui-Cheng Lee has worked with esteemed organizations such as the Institute of Nuclear Energy Research and the Atomic Energy Council. His experience in these institutions has contributed to his expertise in nuclear imaging and cancer diagnostics.

Collaborations

He has collaborated with notable colleagues, including Chun-Chia Cheng and Mei-Hui Wang, to advance research in cancer detection methodologies.

Conclusion

Shui-Cheng Lee's innovative approaches to cancer detection through his patented methods represent a significant advancement in medical diagnostics. His work not only enhances the accuracy of cancer diagnosis but also paves the way for safer and more effective treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…